In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

Panelists discuss the critical importance of early biologic therapy initiation in hidradenitis suppurativa to prevent irreversible tissue damage, reduce disease burden, and overcome socioeconomic and ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing hidradenitis suppurativa severity and pain, especially in patients with obesity.

Discover a study validating a disease-specific quality-of-life tool for hidradenitis suppurativa, confirming its reliability, ...

GLP-1 RA therapy reduces hidradenitis suppurativa severity, flares, symptoms, and BMI in patients with hidradenitis ...

We came across a bullish thesis on MoonLake Immunotherapeutics on Valueinvestorsclub.com by skimmer610. In this article, we ...

Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Study Overview: Incyte Corporation is conducting a Phase ...

Hidradenitis suppurativa patients face higher depression and anxiety risks, but biologic treatments may reduce these mental ...

A new study published in the Journal of American Medical Association showed that new-onset anxiety and sadness were more ...

Hidradenitis suppurativa (HS) is a chronic condition of the sebaceous glands that commonly occurs in those prone to acne. Although there is no cure, the condition can be managed through medications.

Finally, it’s also important to pay attention to your mental health when you have hidradenitis suppurativa; people with HS have a higher risk of depression, anxiety, and low self-esteem.